ProfileGDS4516 / 231166_at
TitleColorectal cancer: laser microdissected tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 1 stage: 2a stage: 2b stage: 3a stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM537341 GSM537345 GSM537355 GSM537366 GSM537370 GSM537380 GSM537392 GSM537415 GSM537417 GSM537422 GSM537423 GSM537427 GSM537430 GSM537336 GSM537337 GSM537348 GSM537349 GSM537356 GSM537361 GSM537374 GSM537377 GSM537378 GSM537379 GSM537383 GSM537388 GSM537395 GSM537400 GSM537404 GSM537409 GSM537418 GSM537425 GSM537333 GSM537342 GSM537347 GSM537350 GSM537362 GSM537363 GSM537368 GSM537376 GSM537381 GSM537386 GSM537398 GSM537402 GSM537405 GSM537371 GSM537421 GSM537424 GSM537432 GSM537331 GSM537332 GSM537334 GSM537338 GSM537353 GSM537357 GSM537358 GSM537375 GSM537389 GSM537390 GSM537393 GSM537399 GSM537407 GSM537408 GSM537428 GSM537354 GSM537410 GSM537413 GSM537396 GSM537397 GSM537330 GSM537369 GSM537373 GSM537401 GSM537343 GSM537367 GSM537382 GSM537385 GSM537391 GSM537419 GSM537420 GSM537429 GSM537431 GSM537387 GSM537414 GSM537433 GSM537335 GSM537339 GSM537340 GSM537344 GSM537346 GSM537351 GSM537352 GSM537359 GSM537360 GSM537364 GSM537365 GSM537372 GSM537384 GSM537394 GSM537403 GSM537406 GSM537411 GSM537412 GSM537416 GSM537426 85% 24% 64% 72% 34% 40% 19% 80% 16% 10% 29% 35% 28% 16% 15% 38% 89% 44% 3% 27% 13% 64% 7% 42% 64% 11% 9% 60% 66% 37% 32% 7% 65% 23% 17% 12% 15% 10% 13% 40% 45% 29% 81% 15% 20% 11% 18% 20% 37% 61% 31% 24% 7% 32% 8% 13% 54% 8% 4% 40% 20% 37% 10% 12% 36% 84% 85% 41% 37% 13% 34% 18% 69% 51% 27% 93% 28% 61% 91% 73% 24% 25% 5% 62% 57% 38% 15% 38% 20% 3% 16% 35% 17% 2% 16% 13% 7% 57% 7% 72% 16% 80% 32% 65% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM537341patient 115, cancer, LCM [OPG study]8.5116785
GSM537345patient 119, cancer, LCM [OPG study]4.0482524
GSM537355patient 138, cancer, LCM [OPG study]6.3776364
GSM537366patient 154, cancer, LCM [OPG study]7.0096772
GSM537370patient 022, cancer, LCM [OPG study]4.4776634
GSM537380patient 037, cancer, LCM [OPG study]4.8340540
GSM537392patient 077, cancer, LCM [OPG study]3.8168219
GSM537415patient 032, cancer, LCM [OPG study]8.1022580
GSM537417patient 042, cancer, LCM [OPG study]3.8168416
GSM537422patient 059, cancer, LCM [OPG study]3.4998310
GSM537423patient 064, cancer, LCM [OPG study]4.2608129
GSM537427patient 084, cancer, LCM [OPG study]4.5248435
GSM537430patient 090, cancer, LCM [OPG study]4.2444928
GSM537336patient 107, cancer, LCM [OPG study]3.6987916
GSM537337patient 108, cancer, LCM [OPG study]3.6455915
GSM537348patient 124, cancer, LCM [OPG study]4.7206238
GSM537349patient 125, cancer, LCM [OPG study]9.2658889
GSM537356patient 139, cancer, LCM [OPG study]5.0714944
GSM537361patient 147, cancer, LCM [OPG study]3.221223
GSM537374patient 026, cancer, LCM [OPG study]4.2168627
GSM537377patient 033, cancer, LCM [OPG study]3.6560413
GSM537378patient 034, cancer, LCM [OPG study]6.369364
GSM537379patient 036, cancer, LCM [OPG study]3.382847
GSM537383patient 046, cancer, LCM [OPG study]4.939742
GSM537388patient 063, cancer, LCM [OPG study]6.4269864
GSM537395patient 082, cancer, LCM [OPG study]3.4990911
GSM537400patient 099, cancer, LCM [OPG study]3.462419
GSM537404patient 129, cancer, LCM [OPG study]6.0757760
GSM537409patient 141, cancer, LCM [OPG study]6.5671966
GSM537418patient 044, cancer, LCM [OPG study]4.6129137
GSM537425patient 070, cancer, LCM [OPG study]4.4455232
GSM537333patient 102, cancer, LCM [OPG study]3.377367
GSM537342patient 116, cancer, LCM [OPG study]6.4271965
GSM537347patient 123, cancer, LCM [OPG study]4.0929223
GSM537350patient 127, cancer, LCM [OPG study]3.7880617
GSM537362patient 148, cancer, LCM [OPG study]3.6169412
GSM537363patient 150, cancer, LCM [OPG study]3.6772815
GSM537368patient 156, cancer, LCM [OPG study]3.4912710
GSM537376patient 031, cancer, LCM [OPG study]3.6307913
GSM537381patient 038, cancer, LCM [OPG study]4.8402640
GSM537386patient 057, cancer, LCM [OPG study]5.1308845
GSM537398patient 094, cancer, LCM [OPG study]4.2776229
GSM537402patient 109, cancer, LCM [OPG study]8.0771281
GSM537405patient 130, cancer, LCM [OPG study]3.7386415
GSM537371patient 023, cancer, LCM [OPG study]3.9209220
GSM537421patient 055, cancer, LCM [OPG study]3.525211
GSM537424patient 065, cancer, LCM [OPG study]3.8461618
GSM537432patient 097, cancer, LCM [OPG study]3.8965120
GSM537331patient 100, cancer, LCM [OPG study]4.678137
GSM537332patient 101, cancer, LCM [OPG study]6.1484661
GSM537334patient 103, cancer, LCM [OPG study]4.3961631
GSM537338patient 110, cancer, LCM [OPG study]4.0504224
GSM537353patient 135, cancer, LCM [OPG study]3.338117
GSM537357patient 142, cancer, LCM [OPG study]4.3715832
GSM537358patient 143, cancer, LCM [OPG study]3.396968
GSM537375patient 030, cancer, LCM [OPG study]3.6158713
GSM537389patient 068, cancer, LCM [OPG study]5.6317654
GSM537390patient 072, cancer, LCM [OPG study]3.385198
GSM537393patient 078, cancer, LCM [OPG study]3.212124
GSM537399patient 095, cancer, LCM [OPG study]4.8750340
GSM537407patient 133, cancer, LCM [OPG study]3.9399520
GSM537408patient 140, cancer, LCM [OPG study]4.6739937
GSM537428patient 086, cancer, LCM [OPG study]3.5045810
GSM537354patient 136, cancer, LCM [OPG study]3.5614912
GSM537410patient 146, cancer, LCM [OPG study]4.626336
GSM537413patient 027, cancer, LCM [OPG study]8.6904984
GSM537396patient 083, cancer, LCM [OPG study]8.6228685
GSM537397patient 088, cancer, LCM [OPG study]4.8848141
GSM537330patient 006, cancer, LCM [OPG study]4.7152237
GSM537369patient 015, cancer, LCM [OPG study]3.6235513
GSM537373patient 025, cancer, LCM [OPG study]4.5360734
GSM537401patient 106, cancer, LCM [OPG study]3.8324218
GSM537343patient 117, cancer, LCM [OPG study]6.7466869
GSM537367patient 155, cancer, LCM [OPG study]5.4763551
GSM537382patient 041, cancer, LCM [OPG study]4.1844227
GSM537385patient 053, cancer, LCM [OPG study]9.8610493
GSM537391patient 073, cancer, LCM [OPG study]4.2396428
GSM537419patient 045, cancer, LCM [OPG study]6.1707261
GSM537420patient 052, cancer, LCM [OPG study]9.2250591
GSM537429patient 089, cancer, LCM [OPG study]7.2470673
GSM537431patient 096, cancer, LCM [OPG study]4.1422124
GSM537387patient 061, cancer, LCM [OPG study]4.0834525
GSM537414patient 028, cancer, LCM [OPG study]3.258125
GSM537433patient 098, cancer, LCM [OPG study]6.2171262
GSM537335patient 104, cancer, LCM [OPG study]5.8220557
GSM537339patient 111, cancer, LCM [OPG study]4.6356538
GSM537340patient 113, cancer, LCM [OPG study]3.7096315
GSM537344patient 118, cancer, LCM [OPG study]4.7515538
GSM537346patient 011, cancer, LCM [OPG study]3.9014620
GSM537351patient 128, cancer, LCM [OPG study]3.174493
GSM537352patient 134, cancer, LCM [OPG study]3.6963316
GSM537359patient 144, cancer, LCM [OPG study]4.6197535
GSM537360patient 145, cancer, LCM [OPG study]3.7510117
GSM537364patient 152, cancer, LCM [OPG study]3.135442
GSM537365patient 153, cancer, LCM [OPG study]3.7304416
GSM537372patient 024, cancer, LCM [OPG study]3.6358513
GSM537384patient 048, cancer, LCM [OPG study]3.384787
GSM537394patient 081, cancer, LCM [OPG study]5.880757
GSM537403patient 121, cancer, LCM [OPG study]3.354697
GSM537406patient 131, cancer, LCM [OPG study]7.0919972
GSM537411patient 149, cancer, LCM [OPG study]3.8135216
GSM537412patient 019, cancer, LCM [OPG study]7.8993780
GSM537416patient 035, cancer, LCM [OPG study]4.3729132
GSM537426patient 079, cancer, LCM [OPG study]6.515365